Understanding Vitiligo: Symptoms, Causes, and Treatment

F.A.Q.

The progression of vitiligo is unpredictable. For some people, the white patches may spread very slowly or remain stable for years without any change. For others, the condition can be rapidly progressive, with new patches appearing over a shorter period.

Vitiligo is a chronic, long-term condition for which there is currently no cure. Available treatments aim to restore skin color to the white patches by affecting skin cells. However, these effects are often temporary, and it's possible for the restored pigment to fade again over time, or for new patches to appear.

Several key triggers have been identified that may cause vitiligo to appear for the first time or cause existing patches to spread. These include severe sunburn, significant emotional stress, and physical trauma or injury to the skin.

 A newer class of medications known as Janus Kinase (JAK) inhibitors represents a significant advancement in vitiligo treatment. Opzelura (Ruxolitinib) cream is a recently approved topical JAK inhibitor. In the UK, Opzelura is the only treatment of this kind approved by the MHRA (as of July 2023) and is currently undergoing appraisal by NICE for availability through the NHS. It is prescribed for the treatment of non-segmental vitiligo in adults and children aged 12 and older. At the same time, well-established and long-proven treatments such as topical therapies and phototherapy remain widely used. These methods have been studied for many years and continue to deliver good results for many people, either on their own or alongside newer options.